Ursodeoxycholic acid induces sarcopenia associated with decreased protein synthesis and autophagic flux

dc.contributor.authorOrozco‐Aguilar, Josué
dc.contributor.authorFranco Tacchi, Franco
dc.contributor.authorValero‐Breton, Mayalen
dc.contributor.authorCastro-Sepulveda, Mauricio
dc.contributor.authorSimon, Felipe
dc.contributor.authorCabello‐Verrugio, Claudio
dc.date.accessioned2024-11-28T14:33:02Z
dc.date.available2024-11-28T14:33:02Z
dc.date.issued2023-05-27
dc.description.abstractBackground Skeletal muscle generates force and movements and maintains posture. Under pathological conditions, muscle fibers suffer an imbalance in protein synthesis/degradation. This event causes muscle mass loss and decreased strength and muscle function, a syndrome known as sarcopenia. Recently, our laboratory described secondary sarcopenia in a chronic cholestatic liver disease (CCLD) mouse model. Interestingly, the administration of ursodeoxycholic acid (UDCA), a hydrophilic bile acid, is an effective therapy for cholestatic hepatic alterations. However, the effect of UDCA on skeletal muscle mass and functionality has never been evaluated, nor the possible involved mechanisms. Methods We assessed the ability of UDCA to generate sarcopenia in C57BL6 mice and develop a sarcopenic-like phenotype in C2C12 myotubes and isolated muscle fibers. In mice, we measured muscle strength by a grip strength test, muscle mass by bioimpedance and mass for specific muscles, and physical function by a treadmill test. We also detected the fiber's diameter and content of sarcomeric proteins. In C2C12 myotubes and/or isolated muscle fibers, we determined the diameter and troponin I level to validate the cellular effect. Moreover, to evaluate possible mechanisms, we detected puromycin incorporation, p70S6K, and 4EBP1 to evaluate protein synthesis and ULK1, LC3 I, and II protein levels to determine autophagic flux. The mitophagosome-like structures were detected by transmission electron microscopy. Results UDCA induced sarcopenia in healthy mice, evidenced by decreased strength, muscle mass, and physical function, with a decline in the fiber's diameter and the troponin I protein levels. In the C2C12 myotubes, we observed that UDCA caused a reduction in the diameter and content of MHC, troponin I, puromycin incorporation, and phosphorylated forms of p70S6K and 4EBP1. Further, we detected increased levels of phosphorylated ULK1, the LC3II/LC3I ratio, and the number of mitophagosome-like structures. These data suggest that UDCA induces a sarcopenic-like phenotype with decreased protein synthesis and autophagic flux. Conclusions Our results indicate that UDCA induces sarcopenia in mice and sarcopenic-like features in C2C12 myotubes and/or isolated muscle fibers concomitantly with decreased protein synthesis and alterations in autophagic flux.
dc.identifier.citationBiological Research, Vol. 56, N°28 (2023) p. 1-19.
dc.identifier.doihttps://doi.org/10.1186/s40659023004318
dc.identifier.issn0717-6287
dc.identifier.orcidhttps://orcid.org/0000-0002-2270-299X
dc.identifier.urihttp://hdl.handle.net/20.500.12254/3937
dc.language.isoen
dc.publisherMBC
dc.rightsAtribución-NoComercial-CompartirIgual 3.0 Chile (CC BY-NC-SA 3.0 CL)
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/cl/
dc.subjectSarcopenia
dc.subjectUrsodeoxycholic acid
dc.subjectAutophagic flux
dc.subjectProtein synthesis
dc.subjectBile acids
dc.titleUrsodeoxycholic acid induces sarcopenia associated with decreased protein synthesis and autophagic flux
dc.typeArticle
Archivos
Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
s40659-023-00431-8.pdf
Tamaño:
4.8 MB
Formato:
Adobe Portable Document Format
Descripción:
Texto completo
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
347 B
Formato:
Item-specific license agreed upon to submission
Descripción: